Pipeline

Our Pipeline

Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational chemistry to discover small molecule drugs more efficiently than traditional approaches to deliver better medicines, faster.

R & D Pipeline

total pipeline depth
500+ Active Projects
protein AREAS
400+ Unique Targets
Targets with Validated Hits
80+ Targets with Validated Hits
Disease Areas

Atomwise has internal drug discovery programs across many disease areas including oncology, immunology, cardiology, neurology, and rare diseases.

Contact us to learn about licensing opportunities.

Co-Developed Pipeline

Co-Development
Partner
Disease Area
Target
Discovery
Optimization
Preclinical
logo x37
Oncology
PIM3
Oncology
SHP2
Clotting Disorders
Factor XII
Immunology
cGAS
logo x37
Neuroscience
GPCR
Neuroscience
Transcriptional Regulator
logo x37
Oncology
undisclosed
logo x37
Oncology
undisclosed

Learn more about our partnerships, portfolio,
pipeline and career opportunities.

Contact Us